AIC-AMTZ MediValley
Academic
Closed

MeitY GENESIS EiR Grant - at AIC-AMTZ MediValley

Add to Google preferred sources
Quick answer

MeitY GENESIS EiR Grant for MedTech/HealthTech innovators, up to ₹10L, hosted by AIC-AMTZ MediValley.

Funding amount
₹10L (grant)
Funding type
Grant
Provider
AIC-AMTZ MediValley (Academic)
Application deadline
Closed (31 Oct 2025)
Eligible stage
Any stage
Location
Open to startups registered in India

Overview

The MeitY GENESIS Entrepreneur in Residence (EiR) Program - Cohort 2 is a grant-based initiative designed to support early-stage innovators and startups in the MedTech and HealthTech sectors. Backed by the Ministry of Electronics and Information Technology (MeitY) and hosted by AIC-AMTZ MediValley—an incubation centre under NITI Aayog—the program aims to transform innovative concepts into scalable businesses. It is particularly focused on fostering deep-tech entrepreneurship in Tier 2 and Tier 3 cities. Participants receive grant support of up to ₹10 Lakhs, along with access to incubation, mentorship, and the broader MediValley ecosystem. The program is ideal for founders who have an idea or early-stage prototype and are looking for non-dilutive funding and structured guidance to validate and launch their product.

Highlights

  • Grant of up to ₹10 Lakhs with no equity dilution.
  • Focused on MedTech and HealthTech innovations.
  • Open to Indian citizens at ideation, validation, PoC, or prototype stage.
  • Special emphasis on impact in Tier 2 and Tier 3 cities.
  • Backed by MeitY and hosted by AIC-AMTZ MediValley (NITI Aayog initiative).

Who can apply

To apply for the MeitY GENESIS EiR Grant, applicants must be Indian citizens. The startup should be in the ideation, validation, proof-of-concept (PoC), or working prototype stage. Importantly, the startup must not have previously received significant external funding exceeding ₹10 Lakhs, including government grants. The proposed idea must have potential for scalability and measurable impact, particularly in Tier 2 and Tier 3 cities. The innovation should be focused on the MedTech or HealthTech sector.

MeitY GENESIS EiR Grant - at AIC-AMTZ MediValley is open to startups at any stage. It is open to startups registered anywhere in India.

Eligible stage
Any stage
Location
Open to startups registered in India

Deadline & timing

The most recent application window for MeitY GENESIS EiR Grant - at AIC-AMTZ MediValley closed on 31 Oct 2025. Many programmes run repeat cohorts, so it is worth checking the official site for the next round.

What the funding covers

Selected innovators receive a grant of up to ₹10 Lakhs to support their early-stage development. Beyond financial support, participants gain access to AIC-AMTZ MediValley's incubation ecosystem, which includes mentorship from industry experts, networking opportunities, and resources to help refine and scale their product. The program also provides guidance on regulatory and market aspects specific to MedTech and HealthTech.

About the provider

MeitY GENESIS EiR Grant - at AIC-AMTZ MediValley is offered by AIC-AMTZ MediValley, an academic institution. It is delivered directly by AIC-AMTZ MediValley as a grant. You can verify current details and timelines on the provider's official website before applying.

Documents you’ll need

Before you apply to MeitY GENESIS EiR Grant - at AIC-AMTZ MediValley, keep the following documents ready:

  • A pitch deck or short business plan describing the problem, product and traction
  • Company registration documents and PAN
  • Founder identification (PAN / Aadhaar) and brief profiles
  • Recent financial statements or projections
  • Product details — a demo, prototype or working link if available

Exact requirements are confirmed on the official application portal — treat this as a preparation checklist.

Who this is best for

MeitY GENESIS EiR Grant - at AIC-AMTZ MediValley is best suited for startups in India seeking non-dilutive funding of ₹10L. If that describes your startup, review the eligibility criteria above before applying.

Frequently asked questions

What is the MeitY GENESIS EiR Grant?

It is a grant-based program supported by MeitY and hosted by AIC-AMTZ MediValley that provides up to ₹10 Lakhs to MedTech and HealthTech innovators to develop their ideas into scalable businesses.

How much funding is offered?

The program offers a grant of up to ₹10 Lakhs.

What is the application deadline?

The deadline for Cohort 2 is 31st October 2025.

Who can apply for this program?

Indian citizens with startups in the ideation, validation, proof-of-concept, or working prototype stage are eligible. The startup must not have raised external funding exceeding ₹10 Lakhs.

Which sectors are eligible?

The program is specifically for MedTech (medical technology) and HealthTech innovations.

Does the program take equity?

No. This is a grant-based program, so no equity is taken in exchange for the funding.

Is DPIIT or MSME registration required?

The eligibility summary does not mention DPIIT or MSME registration as a requirement.

Is there a focus on specific regions?

Yes, the program prioritizes startups that can create measurable impact in Tier 2 and Tier 3 cities.

What documents are needed to apply?

The program page does not list specific documents, but applicants typically need to submit a pitch deck, proof of identity, and details about their innovation.

How do I apply?

Applications are submitted via a Google Form. The link is available on the official program page.

Who offers MeitY GENESIS EiR Grant - at AIC-AMTZ MediValley?

MeitY GENESIS EiR Grant - at AIC-AMTZ MediValley is offered by AIC-AMTZ MediValley, an academic institution. It is provided as non-dilutive funding.

Alternatives to MeitY GENESIS EiR Grant - at AIC-AMTZ MediValley

Not sure MeitY GENESIS EiR Grant - at AIC-AMTZ MediValley is the right fit, or already applied? These are other grants open to Indian startups that founders shortlist alongside it.

Questions from founders

Ask anything about eligibility, documents or the process — answered by the community.

No questions yet — be the first to ask.